Literature DB >> 18372251

Association of protein phosphatase 1 gamma 1 with spinophilin suppresses phosphatase activity in a Parkinson disease model.

Abigail M Brown1, Anthony J Baucum, Martha A Bass, Roger J Colbran.   

Abstract

Sustained nigrostriatal dopamine depletion increases the serine/threonine phosphorylation of multiple striatal proteins that play a role in corticostriatal synaptic plasticity, including Thr(286) phosphorylation of calcium/calmodulin-dependent protein kinase IIalpha (CaMKIIalpha). Mechanisms underlying these changes are unclear, but protein phosphatases play a critical role in the acute modulation of striatal protein phosphorylation. Here we show that dopamine depletion for periods ranging from 3 weeks to 10 months significantly reduces the total activity of protein phosphatase (PP) 1, but not of PP2A, in whole lysates of rat striatum, as measured using multiple substrates, including Thr(286)-autophosphorylated CaMKIIalpha. Striatal PP1 activity is partially inhibited by a fragment of the PP1-binding protein neurabin-I, Nb-(146-493), because of the selective inhibition of the PP1gamma(1) isoform. The fraction of PP1 activity that is insensitive to Nb-(146-493) was unaffected by dopamine depletion, demonstrating that dopamine depletion specifically reduces the activity of PP1 isoforms that are sensitive to Nb-(146-493) (i.e. PP1gamma(1)). However, total striatal levels of PP1gamma(1) or any other PP1 isoform were unaffected by dopamine depletion, and our previous studies showed that total levels of the PP1 regulatory/targeting proteins DARPP-32, spinophilin, and neurabin were also unchanged. Rather, co-immunoprecipitation experiments demonstrated that dopamine depletion increases the association of PP1gamma(1) with spinophilin in striatal extracts. In combination, these data demonstrate that striatal dopamine depletion inhibits a specific synaptic phosphatase by increasing PP1gamma(1) interaction with spinophilin, perhaps contributing to hyperphosphorylation of synaptic proteins and disruptions of synaptic plasticity and/or dendritic morphology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18372251      PMCID: PMC2386916          DOI: 10.1074/jbc.M801377200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity.

Authors:  P B Allen; V Zachariou; P Svenningsson; A C Lepore; D Centonze; C Costa; S Rossi; G Bender; G Chen; J Feng; G L Snyder; G Bernardi; E J Nestler; Z Yan; P Calabresi; P Greengard
Journal:  Neuroscience       Date:  2006-07-07       Impact factor: 3.590

2.  Phosphorylation of spinophilin modulates its interaction with actin filaments.

Authors:  Linda C Hsieh-Wilson; Fabio Benfenati; Gretchen L Snyder; Patrick B Allen; Angus C Nairn; Paul Greengard
Journal:  J Biol Chem       Date:  2002-11-01       Impact factor: 5.157

3.  Regulation of p70 S6 kinase by complex formation between the Rac guanine nucleotide exchange factor (Rac-GEF) Tiam1 and the scaffold spinophilin.

Authors:  Rachel J Buchsbaum; Beth A Connolly; Larry A Feig
Journal:  J Biol Chem       Date:  2003-01-16       Impact factor: 5.157

Review 4.  Functional plasticity in the organization of signaling complexes in the striatum.

Authors:  Patrick B Allen
Journal:  Parkinsonism Relat Disord       Date:  2004-07       Impact factor: 4.891

5.  Analysis of specific interactions of native protein phosphatase 1 isoforms with targeting subunits.

Authors:  Roger J Colbran; Leigh C Carmody; Patricia A Bauman; Brian E Wadzinski; Martha A Bass
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

6.  Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum.

Authors:  Karima Chergui; Per Svenningsson; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

7.  A protein phosphatase-1gamma1 isoform selectivity determinant in dendritic spine-associated neurabin.

Authors:  Leigh C Carmody; Patricia A Bauman; Martha A Bass; Nirmala Mavila; Anna A DePaoli-Roach; Roger J Colbran
Journal:  J Biol Chem       Date:  2004-03-11       Impact factor: 5.157

Review 8.  DARPP-32: an integrator of neurotransmission.

Authors:  Per Svenningsson; Akinori Nishi; Gilberto Fisone; Jean-Antoine Girault; Angus C Nairn; Paul Greengard
Journal:  Annu Rev Pharmacol Toxicol       Date:  2004       Impact factor: 13.820

9.  Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism.

Authors:  Barbara Picconi; Fabrizio Gardoni; Diego Centonze; Daniela Mauceri; M Angela Cenci; Giorgio Bernardi; Paolo Calabresi; Monica Di Luca
Journal:  J Neurosci       Date:  2004-06-09       Impact factor: 6.167

10.  Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia.

Authors:  Barbara Picconi; Diego Centonze; Kerstin Håkansson; Giorgio Bernardi; Paul Greengard; Gilberto Fisone; M Angela Cenci; Paolo Calabresi
Journal:  Nat Neurosci       Date:  2003-05       Impact factor: 24.884

View more
  16 in total

Review 1.  Structural basis for protein phosphatase 1 regulation and specificity.

Authors:  Wolfgang Peti; Angus C Nairn; Rebecca Page
Journal:  FEBS J       Date:  2012-02-24       Impact factor: 5.542

2.  Identification and validation of novel spinophilin-associated proteins in rodent striatum using an enhanced ex vivo shotgun proteomics approach.

Authors:  Anthony J Baucum; Nidhi Jalan-Sakrikar; Yuxia Jiao; Richard M Gustin; Leigh C Carmody; David L Tabb; Amy-Joan L Ham; Roger J Colbran
Journal:  Mol Cell Proteomics       Date:  2010-02-02       Impact factor: 5.911

3.  Protein phosphatase 1γ isoforms linked interactions in the brain.

Authors:  Sara L C Esteves; Luís Korrodi-Gregório; Cândida Z Cotrim; Paula J M van Kleeff; Sara C Domingues; Odete A B da Cruz e Silva; Margarida Fardilha; Edgar F da Cruz e Silva
Journal:  J Mol Neurosci       Date:  2012-10-19       Impact factor: 3.444

Review 4.  Proteomic Analysis of Postsynaptic Protein Complexes Underlying Neuronal Plasticity.

Authors:  Anthony J Baucum
Journal:  ACS Chem Neurosci       Date:  2017-02-23       Impact factor: 4.418

5.  Loss of Thr286 phosphorylation disrupts synaptic CaMKIIα targeting, NMDAR activity and behavior in pre-adolescent mice.

Authors:  Richard M Gustin; Brian C Shonesy; Stacey L Robinson; Tyler J Rentz; Anthony J Baucum; Nidhi Jalan-Sakrikar; Danny G Winder; Gregg D Stanwood; Roger J Colbran
Journal:  Mol Cell Neurosci       Date:  2011-05-24       Impact factor: 4.314

6.  Mechanisms Regulating the Association of Protein Phosphatase 1 with Spinophilin and Neurabin.

Authors:  Michael C Edler; Asma B Salek; Darryl S Watkins; Harjot Kaur; Cameron W Morris; Bryan K Yamamoto; Anthony J Baucum
Journal:  ACS Chem Neurosci       Date:  2018-06-01       Impact factor: 4.418

7.  Spinophilin directs protein phosphatase 1 specificity by blocking substrate binding sites.

Authors:  Michael J Ragusa; Barbara Dancheck; David A Critton; Angus C Nairn; Rebecca Page; Wolfgang Peti
Journal:  Nat Struct Mol Biol       Date:  2010-03-21       Impact factor: 15.369

8.  Dopamine pathway is highly diverged in primate species that differ markedly in social behavior.

Authors:  Christina M Bergey; Jane E Phillips-Conroy; Todd R Disotell; Clifford J Jolly
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-02       Impact factor: 11.205

9.  Differential association of postsynaptic signaling protein complexes in striatum and hippocampus.

Authors:  Anthony J Baucum; Abigail M Brown; Roger J Colbran
Journal:  J Neurochem       Date:  2012-12-26       Impact factor: 5.372

10.  Chronic intermittent alcohol disrupts the GluN2B-associated proteome and specifically regulates group I mGlu receptor-dependent long-term depression.

Authors:  Tiffany A Wills; Anthony J Baucum; Katherine M Holleran; Yaoyi Chen; Johanna G Pasek; Eric Delpire; David L Tabb; Roger J Colbran; Danny G Winder
Journal:  Addict Biol       Date:  2015-11-08       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.